endocrinology

VANCOUVER, British Columbia — September 16, 2026 AbCellera announced that it will present Phase 2 efficacy and safety data...

REDWOOD CITY, Calif. — September 9, 2026 Rezolute, Inc. provided an update on the U.S. Food and Drug Administration’s...

Las Vegas, Nevada, USA, September 7, 2026 The community-acquired bacterial pneumonia (CABP) treatment market is expected to expand through...

Silver Spring, Maryland, USA, September 5, 2026 The U.S. Food and Drug Administration (FDA) has announced steps intended to...

Boston, Massachusetts, USA, September 1, 2026 Vertex Pharmaceuticals Incorporated has completed its acquisition of Crinetics Pharmaceuticals, Inc., strengthening its...

MONTREAL, Quebec, September 2, 2026 Pendopharm, a division of Pharmascience Inc., in collaboration with Ascendis Pharma A/S, announced that...

Burlington, Mass. – August 27, 2026 Cardurion Pharmaceuticals announced that it will present late-breaking results from two Phase 2...

Carmel, Indiana and Burlington, Massachusetts – August 27, 2026 MBX Biosciences announced that the first patient has been dosed...

Plainsboro, New Jersey, August,11, 2026 Novo Nordisk has announced the nationwide U.S. launch of Awiqli® (insulin icodec-abae) injection 700...

Austin, Texas & New York, August 5, 2026 The Foundation for Angelman Syndrome Therapeutics (FAST) has announced a strategic...